O'Malley Brendan M. 4

What Happened
Brendan M. O'Malley, Senior Vice President and Chief Legal Officer of Abeona Therapeutics (ABEO), sold a total of 11,131 shares in open-market transactions on June 8–9, 2026. He disposed of 4,826 shares at a weighted average price of $5.43 (proceeds $26,203) and 6,305 shares at a weighted average price of $5.30 (proceeds $33,443), for combined proceeds of approximately $59,646. These were sales (not purchases) reported on Form 4.

Key Details

• Dates and prices:
  • 2026-06-08: 4,826 shares sold @ weighted avg $5.43 (total ~$26,203). Price range reported: $5.345–$5.54. (Footnote F2)
  • 2026-06-09: 6,305 shares sold @ weighted avg $5.30 (total ~$33,443). Price range reported: $5.24–$5.47. (Footnote F3)
• Total shares sold: 11,131; total proceeds: ~$59,646.
• Reason: Footnote F1 states the sales were to cover tax obligations associated with the vesting of restricted stock awards (tax withholding).
• Filing/timeliness: The Form 4 was filed on 2026-06-09 reporting transactions on 2026-06-08 and 06-09; the filing does not indicate lateness.
• Shares owned after transaction: Not specified in the information provided on the filing.
• Transaction code: S = sale.

Context
These sales were made to satisfy tax withholding on vested restricted stock awards, a common and routine administrative transaction for executives. Such tax-related sales do not necessarily indicate a change in the insider’s view of the company.